Vol 8, No 3 (2022)
Editorial
Published online: 2022-09-30
What does immunology say to rheumatologists that it does not say to others?
DOI: 10.5603/RF.2022.0013
Rheumatology Forum 2022;8(3):95-97.
Abstract
Not available
References
- Kotyla P. Primary immunodeficiency syndromes-beginning of autoimmunity. Rheumatol Forum. 2015; 1(1): 30–37.
- Janiak P, Smoleńska Ż, Zdrojewski Z. Rheumatic manifestations in cancer patients treated with immune checkpoint inhibitors. Rheumatol Forum. 2022; 8(3): 96–102.
- Sawicka-Gutaj N, Wietrzyk D, Zawalna N, et al. Autoimmune disorders and thyroid function in patients with rheumatoid arthritis after biological treatment. Rheumatol Forum. 2022; 8(3): 109–119.
- Targońska-Stępniak B. Antidiabetic effect of disease-modifying antirheumatic drugs. Rheumatol Forum. 2022; 8(3): 120–126.
- Ptak I, Grygiek-Górniak B, Samborski W. Gout in the course of systemic lupus erythematosus: Literature review and case study report. Rheumatol Forum. 2022; 8(3): 103–108.
- Kopeć-Medrek M, Brońska Z, Pieczyrak R. Diffuse alveolar hemorrhage. Rheumatol Forum. 2022; 8(3): 133–137.
- Kronbichler A, Geetha D, Smith RM, et al. The COVID-19 pandemic and ANCA-associated vasculitis — reports from the EUVAS meeting and EUVAS education forum. Autoimmun Rev. 2021; 20(12): 102986.
- Bołtuć K, Bielejewska A, Coloma-Millar A, et al. Case report: Cyclophosphamide in COVID-19 — when an absolute contraindication is an absolute necessity. F1000Research. 2021; 10: 829.
- Brębowicz M, Kaczmarek L, Brebowicz E, et al. Wrist arthroplasty, good alternative for rheumatoid wrist: case report with literature review . Rheumatol Forum. 2022; 8(3): 127–132.
